Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 18, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 20, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001951400-26-000002
Filed / recorded
Feb 20, 2026, 11:35 PM UTC
Added to OQRO
Oct 2, 2026, 3:52 AM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
AbbVie Inc.
Issuer CIK
1551152
Ticker
ABBV
Reporting person
Perry C Siatis
Relationship
Officer
Officer title
EVP, GC AND SECRETARY
Security
Option (Right to buy)
Table
Derivative (Table II)
Transaction date
Feb 18, 2026
Transaction code
A
Shares / units
19,500
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
19,500
Ownership form
Direct
Amendment
No
Footnotes from the filing
Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 6,500 on February 18, 2027, 6,500 on February 18, 2028, and 6,500 on February 18, 2029.